Author/Authors :
Appendix، نويسنده , , Sandra L. Wong، نويسنده , , Celia Chao، نويسنده , , Michael J. Edwards، نويسنده , , David J. Carlson، نويسنده , , Alison Laidley، نويسنده , , R. Dirk Noyes، نويسنده , , Terre McGlothin، نويسنده , , Philip B. Ley، نويسنده , , Todd Tuttle، نويسنده , , Mark Schadt، نويسنده , , Robert Pennington، نويسنده , , Mary Legenza، نويسنده , , James Morgan، نويسنده , , Kelly M. McMasters، نويسنده , , University of Louisvill، نويسنده ,
Abstract :
Background
The need for axillary nodal staging in favorable histologic subtypes of breast cancer is controversial.
Methods
Patients with clinical stage T1-2, N0 breast cancer were enrolled in a prospective, multi-institutional study. All patients underwent sentinel lymph node (SLN) biopsy followed by completion level I/II axillary dissection.
Results
SLN were identified in 3,106 of 3,324 patients (93%). Axillary metastases were found in 35% and 40% of patients with infiltrating ductal carcinoma and infiltrating lobular carcinoma, respectively. Among tumor subtypes, positive nodes were found in 17% of patients with pure tubular carcinoma, 7% of patients with papillary cancer, 6% of patients with colloid (mucinous) carcinoma, 21% of patients with medullary carcinoma, and 8% of patients with DCIS with microinvasion.
Conclusions
Patients with favorable breast cancer subtypes have a significant rate of axillary nodal metastasis. Axillary nodal staging remains important in such patients; SLN biopsy is an ideal method to obtain this staging information.
Keywords :
breast cancer , Sentinel node biopsy , Axillary lymph node dissection , pathology